Carlos Bonilla
Corporate Officer/Principal presso Carlos J. Bonilla & Associates PL
Patrimonio netto: 2 M $ in data 30/06/2024
Profilo
Carlos J.
Bonilla is currently the Principal of Mr. Bonilla & Associates PL.
Previously, he worked as a Director at XenaCare Holdings, Inc.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
LA ROSA HOLDINGS CORP.
6.68% | 16/04/2024 | 1 010 840 ( 6.68% ) | 2 M $ | 30/06/2024 |
Posizioni attive di Carlos Bonilla
| Società | Posizione | Inizio |
|---|---|---|
| Carlos J. Bonilla & Associates PL | Corporate Officer/Principal | 12/05/2011 |
Precedenti posizioni note di Carlos Bonilla
| Società | Posizione | Fine |
|---|---|---|
XenaCare Holdings, Inc.
 XenaCare Holdings, Inc. Pharmaceuticals: OtherHealth Technology XenaCare Holdings, Inc. engages in the formulation, marketing and distribution of nutrition supplement products. It offers Cobroxin for pain medication, XenaCor and XenaTri for cardiovascular health, XenaZyme Plus supports digestion and SunPill for skin protection against ultraviolet rays. The company was founded by Alan P. Xenakis in June 2005 and is headquartered in Tampa, FL. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
XenaCare Holdings, Inc.
XenaCare Holdings, Inc. Pharmaceuticals: OtherHealth Technology XenaCare Holdings, Inc. engages in the formulation, marketing and distribution of nutrition supplement products. It offers Cobroxin for pain medication, XenaCor and XenaTri for cardiovascular health, XenaZyme Plus supports digestion and SunPill for skin protection against ultraviolet rays. The company was founded by Alan P. Xenakis in June 2005 and is headquartered in Tampa, FL. | Health Technology |
| Carlos J. Bonilla & Associates PL |
- Borsa valori
- Insiders
- Carlos Bonilla
